Martha J. Carter
Chief Regulatory Officer, Aegerion Pharmaceuticals, Inc.
Companies
- ALBIREO PHARMA, INC.Chief Regulatory Officer Nov 30, 2016 to Mar 2, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ALBIREO PHARMA, INC.3,654 shares2Mar 2, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023U 3,656 shares of ALBIREO PHARMA, INC.2
- Jan 23, 2023Sold 120 shares at $43.80 of ALBIREO PHARMA, INC.3
- Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.4
- Jan 19, 2023Granted 55,000 shares of ALBIREO PHARMA, INC.5
- Jan 19, 2023Sold 938 shares at $43.90 of ALBIREO PHARMA, INC.6
- Oct 24, 2022Sold 104 shares at $19.58 of ALBIREO PHARMA, INC.7
- Jul 22, 2022Sold 106 shares at $24.68 of ALBIREO PHARMA, INC.8
- Apr 22, 2022Sold 103 shares at $32.92 of ALBIREO PHARMA, INC.9
- Jan 24, 2022Sold 423 shares at $24.52 of ALBIREO PHARMA, INC.10
- Jan 18, 2022Granted 10,800 shares of ALBIREO PHARMA, INC.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 23, 2023
- 4SEC EDGARForm 4 filed Jan 27, 2023
- 5SEC EDGARForm 4 filed Jan 25, 2023
- 6SEC EDGARForm 4 filed Jan 20, 2023
- 7SEC EDGARForm 4 filed Oct 25, 2022
- 8SEC EDGARForm 4 filed Jul 25, 2022
- 9SEC EDGARForm 4 filed Apr 25, 2022
- 10SEC EDGARForm 4 filed Jan 25, 2022
- 11SEC EDGARForm 4 filed Jan 20, 2022